Company record

Enveda

Updated September 26, 2026 · Presspool

Enveda is a clinical-stage biotechnology company that uses AI to identify molecules made by living organisms and develop them into oral medicines. enveda.com

Funding

Latest announced financing: $311 million, Series E, led by Catalio Capital Management, announced September 23, 2026.

• Listed in the AI startup funding roster for September 21–26, 2026.

Whether AI names Enveda

• Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to September 25, 2026.

A company counts when an AI answer names it or cites its website. Answers vary from run to run, so each count is a dated sample.

Sources

• Enveda
• TechCrunch

Every fact on this page links its source. Corrections need a public source: see Contact.